Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incremental Value of 3T Diffusion-Weighted MRI in Diagnosing Extrahepatic Cholangiocarcinoma

NCT01595217 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.

NCT NCT01595217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01595217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incremental Value of 3T Diffusion-Weighted MRI in Diagnosing Extrahepatic Cholangiocarcinoma
Lead sponsor
China Medical University, China
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2013
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasm, cholangiocarcinoma